Culture Biosciences has secured $5.5 million in funding. Founded by former Google X engineers, the CDMO has harnessed drone delivery technology to support its bioreactor simulation and scale-up services. Led by Section 32, with participation from Refactor Capital and Verily, South San Francisco, California-based firm Culture Biosciences has raised $5.5 million (€4.9 million). The contract development and manufacturing organization (CDMO) is offering biotech firms a digital biomanufacturing platform and bioreactor facilities to run, monitor and analyze bioreactor experiments to assess…

“We can produce the volume we need with more limited manufacturing capacity,” says AstraZeneca in the wake of closing two biologics facilities in Colorado. Last month, AstraZeneca announced plans to consolidate its US biologics manufacturing operations. This included closing facilities in Boulder and Longmont, Colorado less than four years after acquiring them from Amgen, and moving operations to its site in Frederick, Maryland. The restructure aims to drive efficiencies in its operations network, but the Anglo-Swedish firm said it expects…